XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Assets, Current [Abstract]    
Cash and cash equivalents $ 12,551 $ 28,656
Accounts receivable, net of allowances of $1,476 and $1,352 at September 30, 2022 and December 31, 2021, respectively 83,496 71,419
Inventories 84,172 75,027
Income tax receivable 11,104 11,808
Other current assets 12,768 9,372
Total current assets 204,091 196,282
Property, plant and equipment, net of accumulated depreciation of $214,254 and $197,936 at September 30, 2022 and December 31, 2021, respectively 195,084 209,105
Operating lease right-of-use assets 46,164 46,443
Intangible assets, net 77,958 88,718
Investment in joint venture 28,193 34,045
Deferred tax assets 375 314
Other non-current assets 5,750 4,194
Total assets 557,615 579,101
Liabilities, Current [Abstract]    
Accounts payable 45,107 36,710
Accrued salaries, wages and benefits 13,024 17,739
Income tax payable 902 2,072
Current maturities of long-term debt 3,150 3,074
Current portion of operating lease liabilities 5,033 5,704
Other current liabilities 11,351 8,718
Total current liabilities 78,567 74,017
Deferred tax liabilities 6,408 7,456
Long-term debt, net of current portion 154,351 151,052
Operating lease liabilities, net of current portion 51,102 51,295
Other non-current liabilities 10,635 17,289
Total liabilities 301,063 301,109
Commitments and contingencies (Note 9)
Common stock - $0.01 par value per share, 90,000 shares authorized, 43,882 and 43,027 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 439 430
Additional paid-in capital 470,543 474,757
Accumulated deficit (233,184) (219,100)
Accumulated other comprehensive loss (43,032) (31,902)
Total stockholders’ equity 194,766 224,185
Total liabilities, preferred stock, and stockholders’ equity 557,615 579,101
Series D Preferred Stock    
Liabilities, Current [Abstract]    
Series D perpetual preferred stock - $0.01 par value per share, 65 shares authorized, issued and outstanding at September 30, 2022 and December 31, 2021, respectively $ 61,786 $ 53,807